BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23524389)

  • 1. Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms.
    Gallay PA; Ptak RG; Bobardt MD; Dumont JM; Vuagniaux G; Rosenwirth B
    Viruses; 2013 Mar; 5(3):981-97. PubMed ID: 23524389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells.
    Chatterji U; Bobardt MD; Stanfield R; Ptak RG; Pallansch LA; Ward PA; Jones MJ; Stoddart CA; Scalfaro P; Dumont JM; Besseghir K; Rosenwirth B; Gallay PA
    J Biol Chem; 2005 Dec; 280(48):40293-300. PubMed ID: 16199531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.
    Hatziioannou T; Perez-Caballero D; Cowan S; Bieniasz PD
    J Virol; 2005 Jan; 79(1):176-83. PubMed ID: 15596813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
    Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA.
    Yang R; Aiken C
    J Virol; 2007 Apr; 81(8):3749-56. PubMed ID: 17267487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
    Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.
    Coelmont L; Hanoulle X; Chatterji U; Berger C; Snoeck J; Bobardt M; Lim P; Vliegen I; Paeshuyse J; Vuagniaux G; Vandamme AM; Bartenschlager R; Gallay P; Lippens G; Neyts J
    PLoS One; 2010 Oct; 5(10):e13687. PubMed ID: 21060866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A.
    Li Y; Kar AK; Sodroski J
    J Virol; 2009 Nov; 83(21):10951-62. PubMed ID: 19656870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
    Ptak RG; Gallay PA; Jochmans D; Halestrap AP; Ruegg UT; Pallansch LA; Bobardt MD; de Béthune MP; Neyts J; De Clercq E; Dumont JM; Scalfaro P; Besseghir K; Wenger RM; Rosenwirth B
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1302-17. PubMed ID: 18212100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the secondary HIV-1 capsid binding site in the host protein cyclophilin A.
    Peng W; Shi J; Márquez CL; Lau D; Walsh J; Faysal KMR; Byeon CH; Byeon IL; Aiken C; Böcking T
    Retrovirology; 2019 Apr; 16(1):10. PubMed ID: 30947724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular recognition in the HIV-1 capsid/cyclophilin A complex.
    Yoo S; Myszka DG; Yeh C; McMurray M; Hill CP; Sundquist WI
    J Mol Biol; 1997 Jun; 269(5):780-95. PubMed ID: 9223641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques.
    Tipper C; Sodroski JG
    J Virol; 2014 Sep; 88(18):10289-302. PubMed ID: 24991000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.
    Saphire AC; Bobardt MD; Gallay PA
    J Virol; 2002 Mar; 76(5):2255-62. PubMed ID: 11836403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
    Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
    J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
    Sokolskaja E; Sayah DM; Luban J
    J Virol; 2004 Dec; 78(23):12800-8. PubMed ID: 15542632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
    Matsuoka S; Dam E; Lecossier D; Clavel F; Hance AJ
    Retrovirology; 2009 Mar; 6():21. PubMed ID: 19254360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
    Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
    ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.